Anti-CXCL5 + CXCL6 antibody [EP13083]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal CXCL5 antibody. Suitable for IP, WB and reacts with Human, Recombinant fragment - Human samples. Cited in 10 publications.
View Alternative Names
ENA78, SCYB5, CXCL5, C-X-C motif chemokine 5, ENA-78(1-78), Epithelial-derived neutrophil-activating protein 78, Neutrophil-activating peptide ENA-78, Small-inducible cytokine B5, GCP2, SCYB6, CXCL6, C-X-C motif chemokine 6, Chemokine alpha 3, Granulocyte chemotactic protein 2, Small-inducible cytokine B6, CKA-3, GCP-2
- IP
Lab
Immunoprecipitation - Anti-CXCL5 + CXCL6 antibody [EP13083] (AB198505)
CXCL5 + CXCL6 was immunoprecipitated from 0.35 mg of A549 (Human lung carcinoma cell line) whole cell extract with ab198505 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab198505 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1 : A549 (Human lung carcinoma epithelial cell), whole cell lysate, 10µg
Lane 2 : A549 whole cell lysate with the ab198505 at 1/30 dilution
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab198505 in A549 whole cell lysate
All lanes:
Immunoprecipitation - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505) at 1/1000 dilution
All lanes:
A549 (Human lung carcinoma epithelial cell), whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 12 kDa
false
Exposure time: 93s
- WB
Lab
Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (AB198505)
The expression of CXCL5 and CXCL6 is induced by TNF-a and PMA. (PMID 9057843; PMID : 23922745).
ab181602 was used a GAPDH loading control.
All lanes:
Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505) at 1/10000 dilution
Lane 1:
A549 (Human lung carcinoma epithelial cell) starved overnight, whole cell lysate at 15 µg
Lane 2:
A549 (Human lung carcinoma epithelial cell) starved overnight, then treated with 10ng/ml TNF-a, 10nM TPA and 0.1% BSA for 24 hours, whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
false
Exposure time: 10s
- WB
Lab
Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (AB198505)
The expression of CXCL5 and CXCL6 is induced by TNF-a and PMA. (PMID 9057843; PMID : 23922745).
ab181602 was used a GAPDH loading control.
All lanes:
Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (ab198505) at 1/10000 dilution
Lane 1:
HEK-293T cells transfected with an empty expression vector containing His tag, hole cell lysate
Lane 2:
HEK-293T cells transfected with a human CXCL5 expression vector containing His tag, then treated with 600 ng/ml BFA for 3h, whole cell lysate
Lane 3:
HEK-293T cells transfected with a human CXCL6 expression vector containing His tag, then treated with 600 ng/ml BFA for 3h, whole cell lysate
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
false
Exposure time: 10s
Related conjugates and formulations (1)
-
Anti-CXCL5 + CXCL6 antibody [EP13083] - BSA and Azide free
Reactivity data
Product details
The production method for this product has been changed from hybridoma to recombinant on 15th April 2024.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
They coordinate immune response by mediating neutrophil recruitment to inflammatory sites. CXCL5 and CXCL6 often work as a team binding CXCR2 and aiding in protective tissue responses. Their roles extend further as they partake in triggering angiogenesis the formation of new blood vessels under physiological or pathological conditions such as wound healing or cancer. These activities imply their involvement in complex cellular networks and interactions.
Pathways
The involvement of CXCL5 and CXCL6 arises prominently in the NF-kB pathway and the MAPK signaling pathway. These pathways integral to immune and inflammatory responses reflect the chemokines' interaction with proteins like IL-8 and TNF-alpha emphasizing their importance in host defense mechanisms and inflammatory signaling cascades. Their ability to engage with these pathways demonstrates an essential role in modulating the intensity and duration of inflammatory responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Biomedicines 11: PubMed37509721
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 41:111848 PubMed36543124
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 16:166-187 PubMed34379869
2021
Applications
Unspecified application
Species
Unspecified reactive species
Reproductive sciences (Thousand Oaks, Calif.) 29:154-162 PubMed33959890
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of international medical research 49:300060521997718 PubMed33752504
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell stem cell 25:797-813.e9 PubMed31809738
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 10:307 PubMed30984000
2019
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 15:1356-1375 PubMed30774023
2019
Applications
Unspecified application
Species
Unspecified reactive species
Immunity 49:764-779.e9 PubMed30332632
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:13988 PubMed29070875
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com